Cargando…
Sars-Cov-2 Infection and Vaccination in Recipients of Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide (PTCy)-Based Allogeneic Hematopoietic Cell Transplantation (HCT)
Autores principales: | Dimitrova, Dimana, Sponaugle, Jennifer, Bergerson, Jenna R.E., Cohen, Jeffrey I., Freeman, Alexandra F., Notarangelo, Luigi D., Uzel, Gulbu, Lisco, Andrea, Sereti, Irini, Ombrello, Amanda K., Uriarte, Ignacio, Campos, Jessenia, Chai, Amy, Flomerfelt, Francis, Kanakry, Jennifer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930029/ http://dx.doi.org/10.1016/S2666-6367(22)00609-1 |
Ejemplares similares
-
Putative Protective Role of Sars-Cov-2-Specific T Cells in an HCT Patient Transplanted during Active COVID19 Infection
por: Pourhassan, Hoda, et al.
Publicado: (2022) -
Efficacy of a Third Sars-Cov-2 Vaccine Dose in Allogeneic Hemopoietic Cell Recipients: a Systematic Review and Meta-Analysis
por: Rubin, Micah, et al.
Publicado: (2023) -
Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning
por: Dimitrova, Dimana, et al.
Publicado: (2022) -
Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation
por: Xu, Heping, et al.
Publicado: (2008) -
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia
por: Ward, Frank J., et al.
Publicado: (2008)